858
Views
15
CrossRef citations to date
0
Altmetric
Rapid Communication

Use of intravenous lipid emulsion in the resuscitation of a patient with cardiovascular collapse after a severe overdose of quetiapine

&
Pages 501-504 | Received 30 Jan 2013, Accepted 03 May 2013, Published online: 14 Jun 2013

References

  • Tan HH, Hoppe J, Heard K. A systematic review of cardiovascular effects following atypical antipsychotic medication overdose. Am J Emerg Med 2009; 27:607–616.
  • Eyer F, Pfab R, Felgenhauer N, Strubel T, Saugel B, Zilker T. Clinical and analytical features of severe suicidal quietiapine overdoses – a retrospective cohort study. Clin Toxicol 2011; 49:846–853.
  • Ngo A, Ciranni M, Olson KR. Acute quetiapine overdose in adults: a 5-year retrospective case series. Ann Emerg Med 2008; 52:541–547.
  • Ciranni MA, Kearney TE, Olson KR. Comparing acute toxicity of first- and second-generation antipsychotic drugs: a 10-year retrospective cohort study. J Clin Psychiatry 2009; 70:122–129.
  • Cave G, Harvey M, Graudins A. Review article: Intravenous lipid emulsion as antidote: a summary of published human experience. Emerg Med Australas 2011; 23:123–141.
  • Rothschild L, Bern S, Oswald S, Weinberg G. Intravenous lipid emulsion in clinical toxicology. Scand J Trauma Resusc Emerg Med 2010; 18:51.
  • Cave G, Harvey M. Intravenous lipid emulsion as antidote beyond local anaesthetic toxicity: a systemic review. Acad Emerg Med 2009; 16:815–824.
  • French D, Smollin C, Ruan W, Wong A, Drasner K, Wu AH. Partition constant and volume of distribution as predictors of clinical efficacy of lipid rescue for toxological emergencies. Clin Toxicol (Phila) 2011; 49:801–809.
  • Burns MJ. The pharmacology and toxicology of atypical antipsychotic agents. J Toxicol Clin Toxicol 2001; 39:1–14.
  • Keck PE Jr, McElroy SL. Clinical pharmacodynamics and pharmacokinetics of antimanic and mood-stabilizing medications. J Clin Psychiatry 2002; 63:3–11.
  • Lannemyr L, Knudsen K. Severe overdose of quetiapine treated successfully with extracorporeal life support. Clin Toxicol (Phila) 2012; 50:258–261.
  • Aghaienia N, Brahm NC, Lussier KM, Washington NB. Probable quetiapine-mediated prolongation of the QT interval. J Pharm Pract 2011; 24:506–512.
  • Al-Khatib SM, LaPointe NM, Kramer JM, Califf RM. What clinicians should know about the QT interval. JAMA 2003; 289: 2120–2127.
  • Isbister GK, Balit CR. Bupropion overdose: QTc prolongation and its clinical significance. Ann Pharmacother 2003; 37:999–1002.
  • Isbister GK, Friberg LE, Hackett LP, Duffull SB. Pharmacokinetics of quetiapine in overdose and the effect of activated charcoal. Clin Pharmacol Ther 2007; 81:821–827.
  • Heimke C, Dragicevic A, Gründer G, Hätter S, Sachse J, Vernaleken I, Müller MJ. Therapeutic monitoring of new antipsychotic drugs. Ther Drug Monit 2004; 26:156–160.
  • Hunfeld NGM, Westerman EM, Boswijk DJ, de Haas JA, van Putten MJ, Touw DJ. Quetiapine in overdosage: a clinical and pharmacokinetic analysis of 14 cases. Therap Drug Monit 2006; 28: 185–189.
  • Jamaty C, Bailey B, Larocque A, Notebaert E, Sanogo K, Chauny JM. Lipid emulsions in the treatment of acute poisoning: a systemic review of human and animal studies. Clin Toxicol (Phila) 2010; 48:1–27.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.